Skip to content
GLP-1 Decoder

Ozempic for Type 1 Diabetes: Evidence, Eligibility, Coverage

Ozempic is not FDA approved for type 1 diabetes. It is approved for type 2 diabetes, heart risk and kidney disease in type 2 diabetes.

For type 1 diabetes
Not an approved use
Active ingredient
semaglutide
How it is taken
weekly injection

Ozempic, in short

How long it remains in your body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week: after 7 d, half is gone, and after five half-lives (35 d), about 3% is left.

Weight loss in the main trial
Ozempic (SUSTAIN 1)4.7 kgPlacebo1.2 kg

In the SUSTAIN 1 trial of 30 weeks, people with type 2 diabetes lost 4.7 kg, while those on placebo lost 1.2 kg.

Cost over time
202520262027$1,027.51$0List priceSelf-pay

In US dollars, the monthly prices shown are the list price and self-pay offers, as posted on the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

Who qualifies?

Ozempic: who qualifies
SourceWho qualifies
FDA labelUsed along with diet and exercise, this medicine lowers blood sugar in adults with type 2 diabetes.
FDA labelThis medicine lowers the risk of heart-related death, heart attack, or stroke for adults with type 2 diabetes who also have heart disease.
FDA labelThis medicine lowers the chance of worsening kidney disease in adults with type 2 diabetes and chronic kidney disease. It also lowers the chance of kidney failure and of heart-related death.

Sources: FDA label (DailyMed).

For type 1 diabetes, what differs?

Ozempic: label wording for type 1 diabetes
What changesWhat the label says
Low Blood Sugar When Used With Insulin Secretagogues or InsulinCombining it with insulin or a sulfonylurea makes low blood sugar more likely, and those doses may need lowering.
Taken with insulin or sulfonylureasLow blood sugar is more likely if you take this medicine with insulin or a sulfonylurea, including glipizide or glimepiride. Your doctor may reduce the doses of these medicines.

FDA labels: FDA label at DailyMed

Label warnings: FDA label at DailyMed

Coverage for type 1 diabetes

Alternatives for type 1 diabetes

GLP-1 medicines and type 1 diabetes
MedicineFor type 1 diabetesHow it is taken
OzempicNot an approved useweekly injection
WegovyNot an approved useweekly injection or daily tablet
RybelsusNot an approved usedaily tablet
MounjaroNot an approved useweekly injection
ZepboundNot an approved useweekly injection
FoundayoNot an approved usedaily tablet
TrulicityNot an approved useweekly injection
SaxendaNot an approved usedaily injection
VictozaNot an approved usedaily injection
ByettaNot an approved usetwice-daily injection

Sources: FDA label (DailyMed).

Questions to ask your prescriber

Read the full prescribing details for Ozempic on DailyMed.